Mirum Pharmaceuticals (MIRM) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Q3 2025 value amounting to $0.05.
- Mirum Pharmaceuticals' EPS (Weighted Average and Diluted) rose 11666.67% to $0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.86, marking a year-over-year increase of 5865.38%. This contributed to the annual value of -$1.85 for FY2024, which is 5370.12% up from last year.
- Mirum Pharmaceuticals' EPS (Weighted Average and Diluted) amounted to $0.05 in Q3 2025, which was up 11666.67% from -$0.12 recorded in Q2 2025.
- In the past 5 years, Mirum Pharmaceuticals' EPS (Weighted Average and Diluted) ranged from a high of $1.91 in Q4 2021 and a low of -$1.94 during Q2 2023
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.68 (2023), whereas its average is -$0.64.
- In the last 5 years, Mirum Pharmaceuticals' EPS (Weighted Average and Diluted) crashed by 15183.25% in 2022 and then skyrocketed by 11666.67% in 2025.
- Quarter analysis of 5 years shows Mirum Pharmaceuticals' EPS (Weighted Average and Diluted) stood at $1.91 in 2021, then tumbled by 151.83% to -$0.99 in 2022, then rose by 11.9% to -$0.87 in 2023, then skyrocketed by 42.6% to -$0.5 in 2024, then surged by 109.99% to $0.05 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $0.05 for Q3 2025, versus -$0.12 for Q2 2025 and -$0.3 for Q1 2025.